Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer.

Shin DH, Jo JY, Choi M, Kim KH, Bae YK, Kim SS
Exp Mol Med. 2023 Oct;55(10):2220-2237. doi: 10.1038/s12276-023-01091-0. Epub 2023 Oct 2. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.